CIK: 1774690 - Address: C/O Stoke Therapeutics, Inc., 45 Wiggins Avenue, Bedford, MA 01730
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/11/21 17:59
1/8/21
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLeggett ThomasMAOCFOM.d3310.86030D
1/11/21 17:59
1/8/21
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLeggett ThomasMAOCFOS.d-10233.940-3-1000D
12/10/20 16:16
12/8/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLeggett ThomasMAOCFOM.d3310.86030D
12/10/20 16:16
12/8/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLeggett ThomasMAOCFOS.d-10133.780-3-1000D
11/12/20 17:00
11/9/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLeggett ThomasMAOCFOM.d3310.86030D
11/12/20 17:00
11/9/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLeggett ThomasMAOCFOS.d-9932.960-3-1000D
10/9/20 16:12
10/8/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLeggett ThomasMAOCFOM.d3310.86030D
10/9/20 16:12
10/8/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLeggett ThomasMAOCFOS.d-10133.530-3-1000D
9/16/20 18:09
9/14/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLeggett ThomasMAOCFOM.d3310.86030D
9/16/20 18:09
9/14/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLeggett ThomasMAOCFOS.d-9331.000-3-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact